Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01425684 · ClinicalTrials.gov registry record

Brain Circuits in Schizophrenia and Smoking

A clinical trial, sponsored by University of Maryland, Baltimore.

Completed
Registry status
837
Enrollment target

NCT01425684: Completed study, sponsored by University of Maryland, Baltimore.

NCT01425684 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 837 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01425684 has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
837 participants
Enrollment target

Study Summary

The principle aim of the project is to identify the key brain circuits associated with smoking and especially smoking in high risk population. The investigators hope that the study will provide concrete biomarkers for new therapeutic development and ultimately reducing the smoking related health burden.

Trial Details

FieldValue
Enrollment Target 837 participants
Start Date 2010-12-20
Est. Completion 2021-04
University of Maryland, Baltimore

560 total trials

What the finished NCT01425684 record still lists

NCT01425684 is an observational study that tracks outcomes without assigning an intervention. The registered 837 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01425684 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01425684 about?

NCT01425684 is a clinical study titled "Brain Circuits in Schizophrenia and Smoking". The principle aim of the project is to identify the key brain circuits associated with smoking and especially smoking in high risk population. The investigators hope that the study will provide concrete biomarkers for new therapeutic development and ultimately reducing the smoking related health bur...

What is the current status of trial NCT01425684?

This trial is currently completed. The enrollment target is 837 participants. The study started on 2010-12-20. Estimated completion is 2021-04.

Who is sponsoring clinical trial NCT01425684?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422550 · 837 participants

    Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

  • NCT02118467 · 836 participants · Phase 4

    Vasoactive Drugs in Intensive Care Unit

  • NCT03670524 · 835 participants · NA

    Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project

  • NCT04831580 · 840 participants · NA

    A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01425684, the US trial registry maintained by the National Library of Medicine. NCT01425684 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.